Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
Clinical trial NCT02167958 · COMPLETED
Trial details
- NCT number
- NCT02167958
- Sponsor
- Rafic Farah, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-11
- Primary completion
- 2019-09-21
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.